Drug profile · INN
fomepizole
FOMEPIZOLE
fomepizole (FOMEPIZOLE) is a alcohol dehydrogenase class i inhibitor. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
Drug details — fomepizole
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.89
Quick answer
fomepizole (FOMEPIZOLE) is a alcohol dehydrogenase class i inhibitor. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Alcohol dehydrogenase class I inhibitor
Primary target: Alcohol dehydrogenase class I
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Frequently asked questions
What is fomepizole?
fomepizole (FOMEPIZOLE) is a alcohol dehydrogenase class i inhibitor. Associated with Regeneron Ireland Designated Activity Company (DAC). Route of administration: injection. Current US regulatory status: approved.
What is the brand name for fomepizole?
FOMEPIZOLE is a marketed brand name for fomepizole. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fomepizole?
fomepizole has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.